ALPS Biotech Co., Ltd.
National Biotechnology Research Park (Resident company)
Pharmaceutical, Small molecule drugs
Founded in 2017, Alps Biotech is a new drug research and developing company, dedicated to study biological functions of protein and natural product. In the short term, Alps focuses on IP’s generation including the disease biomarkers discovery for developing in vitro diagnostic device (IVD), and immune therapy on oncology, as well as a variety of professional biotechnology service, such as protein/natural products separation, purification and identification technology. UP to now Alps has filed many patents covered early diagnosis, better treatment for good quality of patient’s life. Currently Alps is looking for interested biotech or big pharma to co-development the IP’s also.